
At Medison, we offer hope to patients suffering from rare and severe diseases. Through strategic partnerships with best-in-class biotech companies, we commercialize innovative therapies across global markets.
Our culture is rooted in care, agility, collaboration, and innovation, and we’re united by a shared purpose to make a meaningful difference.
If you’re passionate about driving growth and delivering breakthrough innovation to patients, we invite you to be part of our journey.
We are seeking a driven and experienced Executive Director, Head of Corporate Development to lead Medison’s Corporate Development function. Reporting directly to Medison’s Chief Business Officer, the Head of Corporate Development will be part of the Business Development & Corporate Strategy Division Leadership Team. They will lead valuation and structuring, as well as assess and lead transactions that align with our long-term growth strategy. This is a top leadership role for a proactive, result-oriented professional with deep experience in valuation and transaction execution in the biopharmaceutical industry.
We Offer:
Location: United States, East Coast based. (Greater NY or Greater Boston preferred; remote position)
Reports to: Chief Business Officer
Expected Base Pay Range (USD): $250,000-$330,000 per annum
The successful candidate’s starting base pay will be determined based on job-related skills, experience, qualifications, work location, and market conditions. The expected base pay range for this role may be modified based on market conditions.
Medison is committed to building a diverse and inclusive workplace. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, sexual orientation, gender identity, disability, or protected veteran status.
Application Deadline: Thursday, March 19th, 2026

Medison is redefining global biotech commercialization to change lives.
As the first of its kind unified global commercialization platform, Medison partners with biotech companies to bring breakthrough therapies to patients worldwide, especially those with severe and rare diseases.
We specialize in accelerating access and expanding reach in markets beyond the U.S., Western Europe, and Japan. Our unique affiliate-like model seamlessly integrates commercial, medical, and operational capabilities across diverse regions, enabling biotech innovators to scale globally without compromising on local impact.
By applying creativity, expertise, passion, and a borderless mindset, we’re accelerating access to breakthrough therapies, bringing hope to more lives in more places.
We strongly believe that every patient deserves the same chance to a full life, no matter where they live, and we are here to make that belief a reality.